Valix Medical has received a US patent—10,278,820 (percutaneous valve repair and replacement)—for its heart valve repair and replacement technology. A press release reports that the company is developing transcatheter solutions for patients suffering from valvular heart disease and heart failure.
It adds that Valix Medical technology is distinguished in its approach to offer both repair and replacement treatment in one procedure, noting that “this unique toolbox approach” gives more options for interventional cardiologists to deliver the most effective therapy to this complex condition.
Eli Bar, CEO and founder of Valfix Medical, says: “It is exciting to receive this patent as it confirms our technology patentability; our technology is unique and distinct in the market. This patent granted confirms and protects our core technology and adds significant value to our stakeholders.”
Concurrently with the issuance of this patent, Valfix Medical continues to develop its patent portfolio with other patents in preparation and pending.